A detailed history of Rakuten Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Rakuten Investment Management, Inc. holds 5,107 shares of EXAS stock, worth $278,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,107
Holding current value
$278,842
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$43.04 - $58.51 $219,805 - $298,810
5,107 New
5,107 $221,000
Q3 2024

May 15, 2025

BUY
$42.43 - $70.83 $37,295 - $62,259
879 Added 35.2%
3,376 $229,000
Q2 2024

May 15, 2025

BUY
$41.33 - $74.26 $38,519 - $69,210
932 Added 59.55%
2,497 $105,000
Q1 2024

May 15, 2025

BUY
$56.27 - $73.77 $80,747 - $105,859
1,435 Added 1103.85%
1,565 $108,000
Q4 2023

May 15, 2025

SELL
$59.06 - $75.72 $293,941 - $376,858
-4,977 Reduced 97.45%
130 $9,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.66B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rakuten Investment Management, Inc. Portfolio

Follow Rakuten Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Investment Management, Inc. with notifications on news.